期刊文献+

Newly developed autoimmune cholangitis without relapse of autoimmune pancreatitis after discontinuing prednisolone 被引量:1

Newly developed autoimmune cholangitis without relapse of autoimmune pancreatitis after discontinuing prednisolone
下载PDF
导出
摘要 A 57-year-old man presented with a 2-wk history of painless jaundice and weight loss.He had a large illdefined enhancing mass-like lesion in the uncinate process of the pancreas with stricture of the distal common bile duct.Aspiration cytology of the pancreatic mass demonstrated inflammatory cells without evidence of malignancy.Total serum immunoglobulin G level was slightly elevated,but IgG4 level was normal.After the 2-wk 40 mg prednisolone trial,the patient's symptoms and bilirubin level improved significantly.A follow-up computed tomography(CT) scan showed a dramatic resolution of the pancreatic lesion.A low dose steroid was continued.After six months he self-discontinued prednisolone for 3 wk,and was presented with jaundice again.A CT scan showed newly developed intrahepatic biliary dilatation and marked concentric wall thickening of the common hepatic duct and the proximal common bile duct without pancreatic aggravation.The patient' s IgG4 level was elevated to 2.51 g/L.Prednisolone was started again,after which his serum bilirubin level became normal and the thickening of the bile duct was resolved.This case suggests that autoimmune pancreatitis can progress to other organs that are not involved at the initial diagnosis,even with sustained pancreatic remission. A 57-year-old man presented with a 2-wk history of painless jaundice and weight Iossl He had a large ill- defined enhancing mass-like lesion in the uncinate pro- cess of the pancreas with stricture of the distal common bile duct. Aspiration cytology of the pancreatic mass demonstrated inflammatory cells without evidence of malignancy. Total serum immunoglobulin G level was slightly elevated, but IgG4 level was normal. After the 2-wk 40 mg prednisolone trial, the patient's symptoms and bilirubin level improved significantly. A follow-up computed tomography (CT) scan showed a dramatic resolution of the pancreatic lesion. A low dose steroid was continued. After six months he self-discontinued prednisolone for 3 wk, and was presented with jaundice again. ACT scan showed newly developed intrahepatic biliary dilatation and marked concentric wall thickening of the common hepatic duct and the proximal common bile duct without pancreatic aggravation. The patient' s IgG4 level was elevated to 2.51 g/L. Prednisolone was started again, after which his serum bilirubin level became normal and the thickening of the bile duct was resolved. This case suggests that autoimmune pancre- atitis can progress to other organs that are not involved at the initial diagnosis, even with sustained pancreatic remission.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第41期5990-5993,共4页 世界胃肠病学杂志(英文版)
关键词 自身免疫性 泼尼松龙 胰腺炎 胆管 开发 计算机断层扫描 复发 免疫球蛋白G Autoimmune disease Pancreatitis Cholan-gitis Prednisolone
  • 相关文献

参考文献13

  • 1Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Auto- immune pancreatitis. N Engl J Med 2006; 355:2670-2676.
  • 2Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, Pearson RK, Smyrk TC, Petersen BT, Topazian MD, Taka- hashi N, Farnell MB, Vege SS. Differences in clinical profile and relapse rate of type I versus type 2 autoimmune pancre- atitis. Gastroenterology 2010; 139: 140-148; quiz 140-148.
  • 3Chari ST, Murray JA. Autoimmune pancreatitis, Part II: the relapse. Gastroenterology 2008; 134:625-628.
  • 4Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim MH, KIOppel G, Lerch MM, LOhr M, Notohara K, Okazaki K, Schneider A, Zhang L. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40:352-358.
  • 5Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Patho12004; 28:1114.
  • 6Moon SH, Kim MH, Park DH, Hwang CY, Park SJ, Lee SS, Seo DW, Lee SK. Is a 2-week steroid trial after initial nega- tive investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospec- tive outcome study. Gut 2008; 57:1704-1712.
  • 7Kamisawa T, Okamoto A. Autoimmune pancreatitis: pro- posal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41:613~625.
  • 8Park do H, Kim MH. Intrapancreatic common bile duct involvement of autoimmune pancreatitis: is it really IgG4- associated cholangitis? Gastroenterology 2008; 135: 324-35; author reply 325.
  • 9Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Wata- nabe H, Kanno A, Okumura F, Nishikawa T, Kobayashi K, Ichiya T, Takatori H, Yamakita K, Kubota K, Hamano H, Okamura K, Hirano K, Ito T, Ko SB, Omata M. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58: 1504-1507.
  • 10Kamisawa T, Takuma K, Hara S, Tabata T, Kuruma S, Inaba Y, Gopalakrishna R, Egawa N, Itokawa F, Itoi T. Manage- ment strategies for autoimmune pancreatitis. Expert Opin Pharmacother 2011; 12:2149-2159.

同被引文献16

  • 1Eran Brauner,Jesse Lachter,Offir Ben-Ishay,Euvgeni Vlodavsky,Yoram Kluger.Autoimmune pancreatitis misdiagnosed as a tumor of the head of the pancreas[J].World Journal of Gastrointestinal Surgery,2012,4(7):185-189. 被引量:4
  • 2M. J. Heerde,K. Biermann,P. E. Zondervan,G. Kazemier,C. H. J. Eijck,C. Pek,E. J. Kuipers,H. R. Buuren.Prevalence of Autoimmune Pancreatitis and Other Benign Disorders in Pancreatoduodenectomy for Presumed Malignancy of the Pancreatic Head[J].Digestive Diseases and Sciences.2012(9)
  • 3Qicai Liu,Xinhua Lin,Jingfeng Liu,Ailin Liu,Feng Gao.The ?409 C/T Genotype of PRSS1 Protects Against Pancreatic Cancer in the Han Chinese Population[J].Digestive Diseases and Sciences.2012(2)
  • 4Kazuichi Okazaki,Kazushige Uchida,Toshiro Fukui.Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis[J].Journal of Gastroenterology.2008(6)
  • 5Masao Ota,Yoshihiko Katsuyama,Hideaki Hamano,Takeji Umemura,Akinori Kimura,Kaname Yoshizawa,Kendo Kiyosawa,Hirofumi Fukushima,Seiamak Bahram,Hidetoshi Inoko,Shigeyuki Kawa.Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis[J].Immunogenetics.2007(1)
  • 6I Buch,T Giorgino,G Fabritiis.Complete reconstruction of an enzyme–inhibitor binding process by molecular dynamics simulations[].Proceedings of the National Academy of Sciences of the United States of America.2011
  • 7O Guvench,DJ Price,CL Brooks.Receptor rigidity and ligand mobility in trypsin-ligand complexes[].Proteins.2005
  • 8Sultan M,Werlin S,Venkatasubramani N.Genetic prevalence and characteri-stics in children with recurrent pancreatitis[].Journal of Pediatric Gastroenterology and Nutrition.2012
  • 9Chang MC,Chang YT,Tien YW,Liang PC,Jan IS,Wei SC,Wong JM.T-cell regulatory gene CTLA-4 polymorphism/ haplotype association with autoimmune pancreatitis[].Clinical Chemistry.2007
  • 10Algül H,Chari ST.Lymphotoxin in the pathogenesis of autoim-mune pancreatitis:a new player in the field[].Gastroenterology.2012

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部